Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Leonard

Showing results (671-680 of 686) with videos related to

Pageof 69
Sort By:
Blood|May 31, 2024
Randomized study of induction with bendamustine-rituximab ± bortezomib and maintenance with rituximab ± lenalidomide for MCLMitchell R Smith, Opeyemi A Jegede, Peter Martin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2019
Randomized Phase III Study of Alisertib or Investigator's Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell LymphomaOwen A O'Connor, Muhit Özcan, Eric D Jacobsen, et al.
Blood Advances|February 18, 2026
Patterns of Care and Clinical Outcomes in Systemic Peripheral T-cell Lymphoma: The LEO-MER Prospective Cohort StudyJia Ruan, Zhengming Chen, Melissa C Larson, et al.
British Journal of Haematology|October 31, 2017
Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-RLisa Giulino-Roth, Tara O'Donohue, Zhengming Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2019
Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303Nancy L Bartlett, Wyndham H Wilson, Sin-Ho Jung, et al.
Neuro-Oncology Advances|January 28, 2022
Prospective biomarker study in newly diagnosed glioblastoma: Cyto-C clinical trialCorinne E Griguer, Claudia R Oliva, Christopher S Coffey, et al.
Bone Marrow Transplantation|August 20, 2021
ASTCT, CIBMTR, and EBMT clinical practice recommendations for transplant and cellular therapies in mantle cell lymphomaPashna N Munshi, Mehdi Hamadani, Ambuj Kumar, et al.
Transplantation and Cellular Therapy|August 28, 2021
American Society of Transplantation and Cellular Therapy, Center of International Blood and Marrow Transplant Research, and European Society for Blood and Marrow Transplantation Clinical Practice Recommendations for Transplantation and Cellular Therapies in Mantle Cell LymphomaPashna N Munshi, Mehdi Hamadani, Ambuj Kumar, et al.
European Heart Journal|March 20, 2023
Biomarkers and cardiovascular outcomes in chimeric antigen receptor T-cell therapy recipientsSyed S Mahmood, Peter A Riedell, Stephanie Feldman, et al.
Blood Advances|December 14, 2022
Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphomaNarendranath Epperla, Jeffrey Switchenko, Veronika Bachanova, et al.
Pageof 69

Showing results (671-680 of 686) with videos related to

Sort By:
Pageof 69
Blood|May 31, 2024
Randomized study of induction with bendamustine-rituximab ± bortezomib and maintenance with rituximab ± lenalidomide for MCLMitchell R Smith, Opeyemi A Jegede, Peter Martin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2019
Randomized Phase III Study of Alisertib or Investigator's Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell LymphomaOwen A O'Connor, Muhit Özcan, Eric D Jacobsen, et al.
Blood Advances|February 18, 2026
Patterns of Care and Clinical Outcomes in Systemic Peripheral T-cell Lymphoma: The LEO-MER Prospective Cohort StudyJia Ruan, Zhengming Chen, Melissa C Larson, et al.
British Journal of Haematology|October 31, 2017
Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-RLisa Giulino-Roth, Tara O'Donohue, Zhengming Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2019
Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303Nancy L Bartlett, Wyndham H Wilson, Sin-Ho Jung, et al.
Neuro-Oncology Advances|January 28, 2022
Prospective biomarker study in newly diagnosed glioblastoma: Cyto-C clinical trialCorinne E Griguer, Claudia R Oliva, Christopher S Coffey, et al.
Bone Marrow Transplantation|August 20, 2021
ASTCT, CIBMTR, and EBMT clinical practice recommendations for transplant and cellular therapies in mantle cell lymphomaPashna N Munshi, Mehdi Hamadani, Ambuj Kumar, et al.
Transplantation and Cellular Therapy|August 28, 2021
American Society of Transplantation and Cellular Therapy, Center of International Blood and Marrow Transplant Research, and European Society for Blood and Marrow Transplantation Clinical Practice Recommendations for Transplantation and Cellular Therapies in Mantle Cell LymphomaPashna N Munshi, Mehdi Hamadani, Ambuj Kumar, et al.
European Heart Journal|March 20, 2023
Biomarkers and cardiovascular outcomes in chimeric antigen receptor T-cell therapy recipientsSyed S Mahmood, Peter A Riedell, Stephanie Feldman, et al.
Blood Advances|December 14, 2022
Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphomaNarendranath Epperla, Jeffrey Switchenko, Veronika Bachanova, et al.
Pageof 69